SCHEDULE 13D/A Filed 2026-07-16 Event 2026-07-14 SEC 0000902664-26-003126 →

Celadon Partners SPV 24 → Senti Biosciences Holdings, Inc. SNTI

Stake: 54.60% Shares: 25,748,890 CUSIP: 816944102 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

The Reporting Persons and their affiliates entered into the Merger Agreement for the purpose of acquiring the Issuer's assets relating to its Gene-Circuit-enabled pipeline, including the rights to SENTI-202, through the Merger. Following the Merger, the Issuer is expected to remain a public company with a streamlined operating structure, retaining certain intellectual property, collaborations and early-stage programs focused on its Regulator Dial(TM) technology platform while the remaining business is expected to merge into Parent's subsidiary.

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 2.72

542,766 shares short · -14.3% vs prior

Other 13D/G Filings on Senti Biosciences Holdings, Inc.

Filed	Form	Filer	Stake	Shares
2026-01-20	SCHEDULE	Celadon Partners SPV 24	45.00%	13,511,322	view →
2025-09-02	SCHEDULE	Celadon Partners SPV 24	45.00%	13,404,441	view →
2025-03-17	SCHEDULE	Celadon Partners SPV 24	37.60%	9,777,000	view →
2025-03-10	SCHEDULE	New Enterprise Associates 15, L.P.	14.50%	3,775,615	view →

Other Filings by Celadon Partners SPV 24

Filed	Form	Issuer	Stake	Shares
2026-01-20	SCHEDULE	Senti Biosciences, Inc. SNTI	45.00%	13,511,322	view →
2025-09-02	SCHEDULE	Senti Biosciences, Inc. SNTI	45.00%	13,404,441	view →
2025-03-17	SCHEDULE	Senti Biosciences, Inc. SNTI	37.60%	9,777,000	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →